August 6, 2008
(Date of earliest event reported)
LABORATORY CORPORATION
OF
AMERICA HOLDINGS
DELAWARE | 1-11353 | 13-3757370 | ||
(State or other jurisdiction of Incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
358 SOUTH MAIN STREET, BURLINGTON, NORTH CAROLINA |
27215 | 336-229-1127 | ||
(Address of principal executive offices) | (Zip Code) |
(Registrant's telephone number including area code) |
ITEM 7.01. Regulation FD Disclosure
On August 6, 2008, Laboratory Corporation of America® Holdings (LabCorp®) (NYSE: LH) announced that Bradford T. Smith, Executive Vice President, Corporate Affairs, and Andrew J. Conrad, Ph.D., Chief Scientist and Global Head of Clinical Trials for LabCorp, are scheduled to speak at the Bank of America 2008 Specialty Pharmaceuticals Conference in Southampton, NY. LabCorps presentation is planned for Friday, August 8, 2008 at 10:15 a.m. (Eastern Time).
Exhibits
99.1 Press Release dated August 6, 2008
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Laboratory Corporation of America Holdings (Registrant) |
||||
Date: August 6, 2008 | By: | /s/Bradford T. Smith | ||
Bradford T. Smith, Executive Vice President and Secretary |
||||